サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1751031

若年性特発性関節炎診断の世界市場レポート 2025年

Juvenile Idiopathic Arthritis Diagnostic Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.50円
若年性特発性関節炎診断の世界市場レポート 2025年
出版日: 2025年06月17日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

若年性特発性関節炎診断市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は5.8％で、63億2,000万米ドルに成長します。予測期間中の成長は、研究機関間の共同研究の増加、早期かつ正確な診断ソリューションに対する需要の高まり、自己免疫疾患や炎症性疾患の有病率の増加、政府やヘルスケア機関による取り組み、遠隔医療やデジタルヘルスプラットフォームの台頭などに起因すると考えられます。予測期間における主な動向には、技術の進歩、診断技術の改善、個別化治療アプローチ、診断ツールの革新などがあります。

自己免疫疾患の有病率の上昇は、今後数年間、若年性特発性関節炎（JIA）診断市場の成長を大きく促進すると予想されます。自己免疫疾患は、免疫系が誤って身体の健康な細胞を攻撃し、炎症、組織損傷、慢性的な健康合併症を引き起こす疾患です。自己免疫疾患の罹患率の増加は、環境的誘因、遺伝的要因、ライフスタイルの変化の組み合わせと関連しています。若年性特発性関節炎の場合、これらの疾患によって免疫系が関節の滑膜組織を標的とし、炎症と関節損傷の可能性を引き起こします。例えば、ドイツを拠点とするインタラクティブ・オンライン・プラットフォームであるVersorgungsatlas.deの報告によると、2022年には、7,324万1,305人の被保険者のうち、630万4,340人が少なくとも1つの自己免疫疾患と診断され、有病率は8.61％に達します。したがって、自己免疫疾患の罹患率の増加が若年性特発性関節炎診断薬の需要を牽引しています。

主要企業は、製品提供の拡大、研究能力の強化、世界市場でのプレゼンス強化のために、戦略的パートナーシップを結ぶことが増えています。こうしたパートナーシップは、早期発見とより正確な診断の推進に重点を置いています。例えば、2024年11月、カナダに本社を置くバイオテクノロジー企業Augurex Life Sciences Corp.は、米国に本社を置く診断サービス企業Quest Diagnosticsと、14-3-3ホキ（eta）バイオマーカーの使用を通じて関節リウマチ（RA）の診断と管理を改善するためのパートナーシップを締結しました。この共同研究の一環として、クエスト・ダイアグノスティックス社は、オーグレックス社の14-3-3ホキ・バイオマーカーに基づき、米国においてラボで開発された検査を検証・提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界若年性特発性関節炎診断 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の若年性特発性関節炎診断市場：成長率分析
  • 世界の若年性特発性関節炎診断市場の実績：規模と成長, 2019-2024
  • 世界の若年性特発性関節炎診断市場の予測：規模と成長, 2024-2029, 2034F
  • 世界若年性特発性関節炎診断総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の若年性特発性関節炎診断市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 血清学的検査
  • 画像検査
  • 遺伝子検査
  • 世界の若年性特発性関節炎診断市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 分子診断
  • 免疫測定
  • フローサイトメトリー
  • 世界の若年性特発性関節炎診断市場：サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 診断サービス
  • コンサルティングサービス
  • ラボサービス
  • 世界の若年性特発性関節炎診断市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院の検査室
  • 診断センター
  • 調査機関
  • 世界の若年性特発性関節炎診断市場血清学的検査の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
  • リウマトイド因子（RF）検査
  • 抗核抗体（ANA）検査
  • 赤血球沈降速度（ESR）検査
  • C反応性タンパク質（CRP）検査
  • 抗環状シトルリン化ペプチド（抗CCP）検査
  • 全血球数（CBC）
  • 世界の若年性特発性関節炎診断市場画像検査の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
  • X線
  • 磁気共鳴画像法（MRI）
  • 超音波
  • コンピュータ断層撮影（CT）スキャン
  • 骨シンチグラフィー（骨スキャン）
  • 世界の若年性特発性関節炎診断市場遺伝子検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • HLA-B27遺伝子マーカー検査
  • 全エクソームシーケンシング（WES）
  • 次世代シーケンシング（NGS）
  • ポリメラーゼ連鎖反応（PCR）に基づく検査

第7章 地域別・国別分析

  • 世界の若年性特発性関節炎診断市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の若年性特発性関節炎診断市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 若年性特発性関節炎診断市場：競合情勢
  • 若年性特発性関節炎診断市場：企業プロファイル
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Overview, Products and Services, Strategy and Financial Analysis
    • Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Sysmex Corporation
  • Bio-Rad Laboratories
  • Beckman Coulter Life Sciences
  • DiaSorin
  • Miltenyi Biotec
  • Cytek Biosciences
  • BD Biosciences
  • Angstrom Biotech
  • Sony Biotechnology
  • Theradiag
  • J. Mitra
  • Chimera Biotech
  • Stratedigm
  • Apogee Flow Systems
  • Avecon Healthcare

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 若年性特発性関節炎診断市場2029：新たな機会を提供する国
  • 若年性特発性関節炎診断市場2029：新たな機会を提供するセグメント
  • 若年性特発性関節炎診断市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r34884

Juvenile idiopathic arthritis (JIA) diagnosis refers to the medical procedures and tests used to detect JIA, a chronic autoimmune disorder in children that leads to persistent joint inflammation, pain, and stiffness, which can result in long-term joint damage and mobility challenges. It occurs when the immune system mistakenly attacks the body's own joint tissues due to a combination of genetic and environmental factors, causing inflammation that, if left untreated, can lead to growth problems, vision issues, and a diminished quality of life.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary methods for diagnosing juvenile idiopathic arthritis include serological tests, imaging tests, and genetic tests. Serological tests analyze blood to detect specific markers that suggest inflammation or autoimmune activity related to JIA. Key diagnostic technologies include molecular diagnostics, immunoassays, and flow cytometry. Diagnostic services, consultation services, and laboratory services are provided in settings such as hospital laboratories, diagnostic centers, and research institutions.

The juvenile idiopathic arthritis diagnostic market research report is one of a series of new reports from The Business Research Company that provides juvenile idiopathic arthritis diagnostic market statistics, including the juvenile idiopathic arthritis diagnostic industry's global market size, regional shares, competitors with a juvenile idiopathic arthritis diagnostic market share, detailed juvenile idiopathic arthritis diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the juvenile idiopathic arthritis diagnostic industry. This juvenile idiopathic arthritis diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The juvenile idiopathic arthritis diagnostic market size has grown strongly in recent years. It will grow from$4.75 billion in 2024 to $5.04 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to the rising prevalence of juvenile idiopathic arthritis, increased awareness of pediatric autoimmune disorders, early detection initiatives, greater healthcare investments, and a heightened focus on pediatric care.

The juvenile idiopathic arthritis diagnostic market size is expected to see strong growth in the next few years. It will grow to$6.32 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth during the forecast period can be attributed to growing collaborations between research institutions, rising demand for early and accurate diagnostic solutions, increasing prevalence of autoimmune and inflammatory disorders, initiatives by government and healthcare organizations, and the rise of telemedicine and digital health platforms. Key trends in the forecast period include technological advancements, improvements in diagnostic technologies, personalized treatment approaches, and innovations in diagnostic tools.

The rising prevalence of autoimmune disorders is expected to significantly drive the growth of the juvenile idiopathic arthritis (JIA) diagnostic market in the coming years. Autoimmune disorders are conditions in which the immune system erroneously attacks the body's healthy cells, causing inflammation, tissue damage, and chronic health complications. The increasing incidence of autoimmune diseases is linked to a combination of environmental triggers, genetic factors, and lifestyle changes. In the case of juvenile idiopathic arthritis, these disorders cause the immune system to target the synovial tissue in joints, leading to inflammation and potential joint damage. For instance, a report from Versorgungsatlas.de, a Germany-based interactive online platform, indicated that in 2022, among 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, representing a prevalence rate of 8.61%. Therefore, the growing incidence of autoimmune disorders is driving the demand for juvenile idiopathic arthritis diagnostics.

Leading companies in the juvenile idiopathic arthritis diagnostic market are increasingly forming strategic partnerships to expand their product offerings, enhance research capabilities, and strengthen their global market presence. These partnerships focus on advancing early detection and more accurate diagnosis. For example, in November 2024, Augurex Life Sciences Corp., a biotechnology company based in Canada, entered into a partnership with Quest Diagnostics, a US-based diagnostic services company, to improve the diagnosis and management of rheumatoid arthritis (RA) through the use of the 14-3-3η (eta) biomarker. As part of the collaboration, Quest Diagnostics will validate and offer a lab-developed test in the United States based on Augurex's 14-3-3η biomarker, which helps detect elevated levels of the 14-3-3η protein-associated with rheumatoid arthritis and a higher risk of joint damage and disease severity.

In September 2023, Globus Medical Inc., a US-based medical device company, merged with NuVasive Inc. to offer surgeons and patients a comprehensive range of musculoskeletal procedural solutions and advanced technologies. This merger aims to improve the overall continuum of care, expand the companies' global operations, and significantly enhance their portfolios in arthritis and orthopedic treatments. NuVasive, a US-based company, specializes in developing medical devices and procedures focused on orthopedic and idiopathic conditions.

Major players in the juvenile idiopathic arthritis diagnostic market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Agilent Technologies, Sartorius AG, Sysmex Corporation, Bio-Rad Laboratories, Beckman Coulter Life Sciences, DiaSorin, Miltenyi Biotec, Cytek Biosciences, BD Biosciences, Angstrom Biotech, Sony Biotechnology, Theradiag, J. Mitra, Chimera Biotech, Stratedigm, Apogee Flow Systems, and Avecon Healthcare.

North America was the largest region in the juvenile idiopathic arthritis diagnostic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in juvenile idiopathic arthritis diagnostic report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the juvenile idiopathic arthritis diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The juvenile idiopathic arthritis diagnostic market consists of revenues earned by entities by providing services such as clinical evaluations, blood tests, ophthalmologic screenings, bone density scans, and synovial fluid analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The juvenile idiopathic arthritis diagnostic market also includes sales of bone density scanners, AI-based diagnostic software, imaging equipment, and biomarker-based diagnostic panels. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Juvenile Idiopathic Arthritis Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on juvenile idiopathic arthritis diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for juvenile idiopathic arthritis diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The juvenile idiopathic arthritis diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Serological Tests; Imaging Tests; Genetic Tests
  • 2) By Technology: Molecular Diagnostics; Immunoassays; Flow Cytometry
  • 3) By Services: Diagnostic Services; Consultation Services; Laboratory Services
  • 4) By Application: Hospital Laboratories; Diagnostic Centres; Research Institutes
  • Subsegments:
  • 1) By Serological Tests: Rheumatoid Factor (RF) Test, Antinuclear Antibody (ANA) Test, Erythrocyte Sedimentation Rate (ESR) Test, C-Reactive Protein (CRP) Test, Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test, Complete Blood Count (CBC)
  • 2) By Imaging Tests: X-Ray, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT) Scan, Bone Scintigraphy (Bone Scan)
  • 3) By Genetic Tests: HLA-B27 Genetic Marker Test, Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)-Based Testing
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Agilent Technologies; Sartorius AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Juvenile Idiopathic Arthritis Diagnostic Market Characteristics

3. Juvenile Idiopathic Arthritis Diagnostic Market Trends And Strategies

4. Juvenile Idiopathic Arthritis Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Juvenile Idiopathic Arthritis Diagnostic Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Juvenile Idiopathic Arthritis Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate Analysis
  • 5.4. Global Juvenile Idiopathic Arthritis Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Juvenile Idiopathic Arthritis Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Juvenile Idiopathic Arthritis Diagnostic Total Addressable Market (TAM)

6. Juvenile Idiopathic Arthritis Diagnostic Market Segmentation

  • 6.1. Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serological Tests
  • Imaging Tests
  • Genetic Tests
  • 6.2. Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry
  • 6.3. Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Services
  • Consultation Services
  • Laboratory Services
  • 6.4. Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Laboratories
  • Diagnostic Centers
  • Research Institutes
  • 6.5. Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rheumatoid Factor (RF) Test
  • Antinuclear Antibody (ANA) Test
  • Erythrocyte Sedimentation Rate (ESR) Test
  • C-Reactive Protein (CRP) Test
  • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test
  • Complete Blood Count (CBC)
  • 6.6. Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • X-Ray
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound
  • Computed Tomography (CT) Scan
  • Bone Scintigraphy (Bone Scan)
  • 6.7. Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Genetic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • HLA-B27 Genetic Marker Test
  • Whole Exome Sequencing (WES)
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)-Based Testing

7. Juvenile Idiopathic Arthritis Diagnostic Market Regional And Country Analysis

  • 7.1. Global Juvenile Idiopathic Arthritis Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Juvenile Idiopathic Arthritis Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market

  • 8.1. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Juvenile Idiopathic Arthritis Diagnostic Market

  • 9.1. China Juvenile Idiopathic Arthritis Diagnostic Market Overview
  • 9.2. China Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Juvenile Idiopathic Arthritis Diagnostic Market

  • 10.1. India Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Juvenile Idiopathic Arthritis Diagnostic Market

  • 11.1. Japan Juvenile Idiopathic Arthritis Diagnostic Market Overview
  • 11.2. Japan Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Juvenile Idiopathic Arthritis Diagnostic Market

  • 12.1. Australia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market

  • 13.1. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Juvenile Idiopathic Arthritis Diagnostic Market

  • 14.1. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Overview
  • 14.2. South Korea Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market

  • 15.1. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market Overview
  • 15.2. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Juvenile Idiopathic Arthritis Diagnostic Market

  • 16.1. UK Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Juvenile Idiopathic Arthritis Diagnostic Market

  • 17.1. Germany Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Juvenile Idiopathic Arthritis Diagnostic Market

  • 18.1. France Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Juvenile Idiopathic Arthritis Diagnostic Market

  • 19.1. Italy Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Juvenile Idiopathic Arthritis Diagnostic Market

  • 20.1. Spain Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market

  • 21.1. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market Overview
  • 21.2. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Juvenile Idiopathic Arthritis Diagnostic Market

  • 22.1. Russia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Juvenile Idiopathic Arthritis Diagnostic Market

  • 23.1. North America Juvenile Idiopathic Arthritis Diagnostic Market Overview
  • 23.2. North America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Juvenile Idiopathic Arthritis Diagnostic Market

  • 24.1. USA Juvenile Idiopathic Arthritis Diagnostic Market Overview
  • 24.2. USA Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Juvenile Idiopathic Arthritis Diagnostic Market

  • 25.1. Canada Juvenile Idiopathic Arthritis Diagnostic Market Overview
  • 25.2. Canada Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Juvenile Idiopathic Arthritis Diagnostic Market

  • 26.1. South America Juvenile Idiopathic Arthritis Diagnostic Market Overview
  • 26.2. South America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Juvenile Idiopathic Arthritis Diagnostic Market

  • 27.1. Brazil Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Juvenile Idiopathic Arthritis Diagnostic Market

  • 28.1. Middle East Juvenile Idiopathic Arthritis Diagnostic Market Overview
  • 28.2. Middle East Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Juvenile Idiopathic Arthritis Diagnostic Market

  • 29.1. Africa Juvenile Idiopathic Arthritis Diagnostic Market Overview
  • 29.2. Africa Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Juvenile Idiopathic Arthritis Diagnostic Market Competitive Landscape And Company Profiles

  • 30.1. Juvenile Idiopathic Arthritis Diagnostic Market Competitive Landscape
  • 30.2. Juvenile Idiopathic Arthritis Diagnostic Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

31. Juvenile Idiopathic Arthritis Diagnostic Market Other Major And Innovative Companies

  • 31.1. Sysmex Corporation
  • 31.2. Bio-Rad Laboratories
  • 31.3. Beckman Coulter Life Sciences
  • 31.4. DiaSorin
  • 31.5. Miltenyi Biotec
  • 31.6. Cytek Biosciences
  • 31.7. BD Biosciences
  • 31.8. Angstrom Biotech
  • 31.9. Sony Biotechnology
  • 31.10. Theradiag
  • 31.11. J. Mitra
  • 31.12. Chimera Biotech
  • 31.13. Stratedigm
  • 31.14. Apogee Flow Systems
  • 31.15. Avecon Healthcare

32. Global Juvenile Idiopathic Arthritis Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Juvenile Idiopathic Arthritis Diagnostic Market

34. Recent Developments In The Juvenile Idiopathic Arthritis Diagnostic Market

35. Juvenile Idiopathic Arthritis Diagnostic Market High Potential Countries, Segments and Strategies

  • 35.1 Juvenile Idiopathic Arthritis Diagnostic Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Juvenile Idiopathic Arthritis Diagnostic Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Juvenile Idiopathic Arthritis Diagnostic Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250617_r34884_Juvenile_Idiopathic_Arthritis_Diagnostic_GMR_2025